Next Article in Journal
Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
Previous Article in Journal
Natural History of Sudan ebolavirus to Support Medical Countermeasure Development
Case Report

Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy

1
Department of Plastic and Reconstructive Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon 14584, Korea
2
Department of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon 14584, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: Christian Napoli
Vaccines 2022, 10(6), 964; https://doi.org/10.3390/vaccines10060964
Received: 2 May 2022 / Revised: 13 June 2022 / Accepted: 14 June 2022 / Published: 16 June 2022
(This article belongs to the Section COVID-19 Vaccines and Vaccination)
Lymphadenopathy after coronavirus disease 2019 (COVID-19) vaccination is a common side effect that usually resolves within several days to weeks, and only observation is recommended. However, for prolonged lymphadenopathy, other possibilities, including malignancy or other lymphoproliferative diseases, may be considered. Herein, we report the case of a 66-year-old woman who experienced prolonged ipsilateral supraclavicular lymph node enlargement after the second dose of the ChAdOx1 (Oxford-AstraZeneca) COVID-19 vaccine, which was eventually diagnosed as extrapulmonary tuberculosis. View Full-Text
Keywords: lymphadenopathy; COVID-19; vaccination; tuberculosis lymphadenopathy; COVID-19; vaccination; tuberculosis
Show Figures

Figure 1

MDPI and ACS Style

Cha, H.G.; Kim, D.G.; Choi, J.H. Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy. Vaccines 2022, 10, 964. https://doi.org/10.3390/vaccines10060964

AMA Style

Cha HG, Kim DG, Choi JH. Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy. Vaccines. 2022; 10(6):964. https://doi.org/10.3390/vaccines10060964

Chicago/Turabian Style

Cha, Han G., Dong G. Kim, and Joon H. Choi. 2022. "Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy" Vaccines 10, no. 6: 964. https://doi.org/10.3390/vaccines10060964

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop